NCT03178786
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- New York University School of Medicine New York, United States
Clinical trial condition
Parkinson Disease
Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.
3,319 public trials
608 recruiting studies
Parkinson Disease trial results
NCT03065192
- Conditions
- Basal Ganglia Disease, Basal Ganglia Diseases, Brain Diseases, +9 more
- Locations
-
- University of California, San Francisco (UCSF) San Francisco, California, United States
- Emory University Atlanta, Georgia, United States
- Ohio State University (OSU) Columbus, Ohio, United States
- University of Pittsburgh Medical Center (UPMC) Pittsburgh, Pennsylvania, United States
NCT05154552
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Sir Ganga Raam Hospital Lahore, Punjab Province, Pakistan
- University of Lahore Teaching Hospital Lahore, Punjab Province, Pakistan
NCT03568760
- Conditions
- Anomia, Aphasia, Autoimmune Diseases, +25 more
- Locations
-
- University of Gothenburg Gothenburg, Västra Göraland, Sweden
Completed
Reliability and Validity of Urdu Version of Mini-BESTest in Persons With Parkinson's Disease
NCT05221099
- Conditions
- Balance, Basal Ganglia Diseases, Brain Diseases, +7 more
- Locations
-
- Ripah International University Faisalabad, Punjab Province, Pakistan
NCT04665622
- Conditions
- Alzheimer Dementia, Alzheimer Disease, Basal Ganglia Diseases, +13 more
- Locations
-
- Centre Hospitalier Princesse Grace Monaco
Completed
A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants
NCT02337751
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Matsuyama, Ehime, Japan
- Tōon, Ehime, Japan
- Kitakyushu, Fukuoka, Japan
NCT02337725
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Matsuyama, Ehime, Japan
- Touon, Ehime, Japan
- Kitakyushu, Fukuoka, Japan
Completed
A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants
NCT02337764
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Matsuyama, Ehime, Japan
- Fukuoka, Fukouka, Japan
- Kōriyama, Fukushima, Japan
Completed
A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants
NCT02337738
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Matsuyama, Ehime, Japan
- Touon, Ehime, Japan
- Kitakyushu, Fukuoka, Japan